Patents Assigned to Diagast
  • Publication number: 20200408749
    Abstract: The present invention relates to an in-vitro diagnosis device for detecting and/or identifying antigen and/or antibody from a sample of biological fluid, particularly from a sample of blood or sample of blood components. The invention also relates to different uses of this device such as the detection and/or the identification of red blood cells antigens, platelet antigens, viralantigens, bacterial antigens, parasite antigens, the detection and/or the identification of anti-red blood cells antibodies, antiplatelet antibodies, antiviral antibodies, antibacterial antibodies and antiparasitic antibodies.
    Type: Application
    Filed: February 15, 2019
    Publication date: December 31, 2020
    Applicant: DIAGAST
    Inventors: Christine BETREMIEUX - MERLIER, Laziza AMNIAI, Julien SCHELPE
  • Patent number: 10591494
    Abstract: The invention relates to an in vitro diagnosis device (10) for the detection of at least one reaction between an erythrocytic phenotype antigen and an antibody specifically directed against said antigen in a sample of blood or one of the components thereof. The device is characterized in that it comprises: a substrate (12); and a hydrophobic porous membrane (14) having a thickness of between 0.5 mm and 1.5 mm and a pore diameter of between 2 and 30 ?m, said membrane comprising at least one hydrophilic reaction zone (16) intended to receive the sample. The invention also relates to the uses of said device in immunohematology.
    Type: Grant
    Filed: June 11, 2013
    Date of Patent: March 17, 2020
    Assignee: Diagast
    Inventors: Najim Chaibi, Sylvain Malgouries, Megumi Lucas
  • Patent number: 9618518
    Abstract: The current invention relates to a magnetic immunodiagnostic method for the demonstration of antibody/antigen complexes of blood group and phenotype. Such a method involves the research and/or identification of antibodies or antigens, preferably anti-antigen antibodies or antigens of a blood group. This method implements a suspension of magnetic particles coated with an antibody anti-glycophorin A that can recognize and specifically magnetize erythrocytes. The invention also includes a device and kit for carrying out one such method.
    Type: Grant
    Filed: July 21, 2011
    Date of Patent: April 11, 2017
    Assignee: DIAGAST
    Inventors: Laurence Fauconnier, Yves Barbreau, Arnaud Boulet, Maha Zakhour
  • Patent number: 8889368
    Abstract: The invention relates to a method for phenotyping blood and/or performing an irregular agglutinin test and/or for determination of compatibility of a donor and receiver, using an aqueous solution of ferrofluid, obtained from a mixture of polyoxoanions of Fe(III) and at least one metal M(II) of oxidation state II. The invention further relates to a kit for carrying out said procedure.
    Type: Grant
    Filed: May 3, 2005
    Date of Patent: November 18, 2014
    Assignee: Diagast
    Inventors: Yves Barbreau, Olivier Boulet, Arnaud Boulet, Alexis Delanoe, Laurence Fauconnier, Jean-Marc Pelosin, Laurent Soufflet
  • Patent number: 8852958
    Abstract: The invention relates to a magnetic immunodiagnostic method for the demonstration of antibody-antigen complexes. One such method involves the research and/or identification of antibodies or antigens, preferably anti-antigen antibodies or antigens of a blood group, and comprises a suspension of magnetic particles coated with antigens that can be carried by cells such as erythrocytes. The invention also relates to a device and a kit for carrying out one such method.
    Type: Grant
    Filed: October 24, 2011
    Date of Patent: October 7, 2014
    Assignee: Diagast
    Inventors: Yves Barbreau, Olivier Boulet, Arnaud Boulet, Alexis Delanoe, Laurence Fauconnier, Fabien Herbert, Jean-Marc Pelosin, Laurent Soufflet
  • Publication number: 20130130280
    Abstract: The current invention relates to a magnetic immunodiagnostic method for the demonstration of antibody/antigen complexes of blood group and phenotype. Such a method involves the research and/or identification of antibodies or antigens, preferably anti-antigen antibodies or antigens of a blood group. This method implements a suspension of magnetic particles coated with an antibody anti-glycophorin A that can recognize and specifically magnetize erythrocytes. The invention also includes a device and kit for carrying out one such method.
    Type: Application
    Filed: July 21, 2011
    Publication date: May 23, 2013
    Applicant: DIAGAST
    Inventors: Laurence Fauconnier, Yves Barbreau, Arnaud Boulet, Maha Zakhour
  • Patent number: 8093067
    Abstract: The invention relates to a magnetic immunodiagnostic method for the demonstration of antibody-antigen complexes. One such method involves the research and/or identification of antibodies or antigens, preferably anti-antigen antibodies or antigens of a blood group, and comprises a suspension of magnetic particles coated with antigens that can be carried by cells such as erythrocytes. The invention also relates to a device and a kit for carrying out one such method.
    Type: Grant
    Filed: November 3, 2006
    Date of Patent: January 10, 2012
    Assignee: Diagast
    Inventors: Yves Barbreau, Olivier Boulet, Arnaud Boulet, Alexis Delanoe, Laurence Fauconnier, Fabien Herbert, Jean-Marc Pelosin, Laurent Soufflet